small molecule glp-1 agonist Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1: Cell Metabolism In the ATTAIN-1 phase 3,

One such MSIA, termed IGF-1 MSIA-SRM, has been developed for IGF-1 with improved protocols for disrupting the IGF-1/IGFBP complex and for monitoring the immunoassays efficiency from sample preparation to mass spectrometric detection

Whole leaf and standardized extract are measured differently, so match the form to the dose you are trying to follow

In the treatment of SLE, statins not only regulate lipid metabolism but also exert beneficial immunomodulatory effects, offering therapeutic advantages to SLE patients

Transparency is another key pillar of trust

453O DS-7300 (B7-H3 DXd antibody-drug conjugate [ADC]) shows durable antitumor activity in advanced solid tumors: extended follow-up of a phase I/II study